Clinical Trial Update: Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide Fixed Dose Combination in Adolescents and Children With Human Immunodeficiency Virus-1 [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update covers the pediatric/adolescent study of the fixed-dose HIV regimen bictegravir/emtricitabine/tenofovir alafenamide, with the trial c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• BIKTARVY (BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV-1 Infection | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING